Research at the Aflac Cancer Center

Pediatric Research

FIND A CLINICAL TRIAL

Every advancement in curing childhood cancer is the result of research.

At the Aflac Cancer and Blood Disorders Center, we are committed to excellence and innovation in pediatric cancer and blood disorders research. Our rapidly growing research program includes physicians and Ph.D.s in the following fields of study: BMT, brain tumors, cancer survivorship, leukemia/lymphoma, solid tumors, hemostasis/thrombosis, sickle cell diseasegene therapy and transfusion medicine.

At the Aflac Cancer Center, there is a significant opportunity to advance research and teaching in pediatric hematology/oncology. We are uniquely positioned to leverage the vast capabilities in Atlanta through collaborative relationships with:

  • Emory University School of Medicine
  • Emory Winship Cancer Institute
  • Emory University’s Rollins School of Public Health
  • Georgia Institute of Technology
  • Centers for Disease Control and Prevention (CDC)

Additionally, our physicians participate and often play leadership roles in all of the major national collaborative research consortia geared towards the early clinical development of promising therapies for the treatment of cancer and blood disorders, including:

  • Children’s Oncology Group, including the Phase I and Pilot Consortium
  • New Approaches to Neuroblastoma Therapy (NANT)
  • Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL)
  • Pediatric Blood and Marrow Transplant Consortium (PBMTC)
  • Transfusion Medicine and Hemostasis Research Network through the NIH
  • Sickle Cell Clinical Research Network through the NIH
     
 
ResearchSpotlight

    The Aflac Cancer Center teams up with the Emory University Winship Cancer Institute and NextBio to improve outcomes for children with medullobastoma. Learn more.

 
     

Learn more

  • Types of research
    The Aflac Cancer Center conducts lab research that focuses on gene therapy, molecular therapy, cell signaling, nanomedicine and genomics. Learn about the four different types of research, including: epidemiology, basic research, translational research and clinical trials.
  • Clinical trials
    The Aflac Cancer Center is home of one of the largest pediatric clinical trial programs in the country—offering our patients access to some of the most novel treatment options in the country. Learn about the the different phases of clinical trials, who can participate and the benefits of participating.
  • Our goals
    The Aflac Cancer Center is committed to excellence and innovation in pediatric cancer and blood disorders research. Read about how we continue to expand our research program.
  • Highlights and accomplishments
    The Aflac Cancer Center is one of only 3 centers in the Southeast that is a member of the Children's Oncology Group (COG) Phase I Consortium. Read about our other highlights and accomplishments.
  • Research collaborations
    At the Aflac Cancer Center, there is a significant opportunity to advance research and teaching in pediatric cancer and blood disorders. Learn how the we are uniquely positioned to leverage the vast capabilities in Atlanta.
  • News and articles
    The Center for Pediatric Nanomedicine (CPN) is the first of its kind in the world. Read other recent news stories and articles.